Report Detail

Request for Sample of this report

Pharma & Healthcare Global Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis 2020 with Top Companies, Production, Consumption,Price and Growth Rate

  • RnM3933441
    • |
  • 19 March, 2020
    • |
  • Global
    • |
  • 110 Pages
    • |
  • XYZResearch
    • |
  • Pharma & Healthcare

In this report,XYZ-research offers a comprehensive analysis of key market trends in the global Gastrointestinal Stromal Tumor (GIST) Drug market. It also includes discussion on historical trends, current market status, competitive landscape, growth opportunities and challenges which are backed by factful feedbacks. The report extensively provides quantitative analysis of the industry from 2014-2026,by Region, Type, Application. Consumption assessment by application, production by type in different regions. Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. The market size in terms of revenue (USD) and production is calculated for the study period along with the details of the factors affecting the market growth (drivers and restraints). The worldwide market for Gastrointestinal Stromal Tumor (GIST) Drugmarket will reach xxx Million USD in 2020 and is expected to grow at a CAGR of xx% 2021-2026.

Geographically, global Gastrointestinal Stromal Tumor (GIST) Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Ariad Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Astex Pharmaceuticals, Inc.
Blueprint Medicines Corporation
Boston Biomedical, Inc.
Calithera Biosciences, Inc.
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals, LLC
F. Hoffmann-La Roche Ltd.
Horizon Pharma Plc
Immunicum AB
Jiangsu Hengrui Medicine Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S.r.l.
Novartis AG
Omeros Corporation

On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others
For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Gastrointestinal Stromal Tumor (GIST) Drug for each application, including
Clinic
Hospital
Others
Production, consumption, revenue, market share and growth rate are the key targets for Gastrointestinal Stromal Tumor (GIST) Drug from 2014 to 2026 (forecast) in these regions
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America

If you have any special requirements, please let us know and we will offer you the report as you want.


Table of Contents

    1 Report Overview

    • 1.1 Definition
    • 1.2 Manufacturers and Regions Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
    • 1.3 Type Overview
    • 1.4 Application Overview
    • 1.5 Industrial Chain
      • 1.5.1 Gastrointestinal Stromal Tumor (GIST) Drug Overall Industrial Chain
      • 1.5.2 Upstream
      • 1.5.3 Downstream
      • 1.5.4 Economic/Political Environment

    2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Assesment by Types

    • 2.1 Overall Market Performance
      • 2.1.1 Product Type Market Performance (Volume)
      • 2.1.2 Product Type Market Performance (Value)
    • 2.2 China Gastrointestinal Stromal Tumor (GIST) Drug Market Performance
    • 2.3 USA Gastrointestinal Stromal Tumor (GIST) Drug Market Performance
    • 2.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Performance
    • 2.5 Japan Gastrointestinal Stromal Tumor (GIST) Drug Market Performance
    • 2.6 Korea Gastrointestinal Stromal Tumor (GIST) Drug Market Performance
    • 2.7 India Gastrointestinal Stromal Tumor (GIST) Drug Market Performance
    • 2.8 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Performance
    • 2.9 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Performance

    3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Assesment by Application

    • 3.1 Overall Market Performance (Volume)
    • 3.2 China Gastrointestinal Stromal Tumor (GIST) Drug Market Performance (Volume)
    • 3.3 USA Gastrointestinal Stromal Tumor (GIST) Drug Market Performance (Volume)
    • 3.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Performance (Volume)
    • 3.5 Japan Gastrointestinal Stromal Tumor (GIST) Drug Market Performance (Volume)
    • 3.6 Korea Gastrointestinal Stromal Tumor (GIST) Drug Market Performance (Volume)
    • 3.7 India Gastrointestinal Stromal Tumor (GIST) Drug Market Performance (Volume)
    • 3.8 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Performance (Volume)
    • 3.9 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Performance (Volume)

    4 Competitive Analysis

    • 4.1 Ariad Pharmaceuticals, Inc.
      • 4.1.1 Ariad Pharmaceuticals, Inc. Profiles
      • 4.1.2 Ariad Pharmaceuticals, Inc. Product Information
      • 4.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price and Gross Margin
      • 4.1.4 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Business Performance
      • 4.1.5 SWOT Analysis
    • 4.2 Arog Pharmaceuticals, Inc.
      • 4.2.1 Arog Pharmaceuticals, Inc. Profiles
      • 4.2.2 Arog Pharmaceuticals, Inc. Product Information
      • 4.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price and Gross Margin
      • 4.2.4 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Business Performance
      • 4.2.5 SWOT Analysis
    • 4.3 Array BioPharma Inc.
      • 4.3.1 Array BioPharma Inc. Profiles
      • 4.3.2 Array BioPharma Inc. Product Information
      • 4.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price and Gross Margin
      • 4.3.4 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Business Performance
      • 4.3.5 SWOT Analysis
    • 4.4 Astex Pharmaceuticals, Inc.
      • 4.4.1 Astex Pharmaceuticals, Inc. Profiles
      • 4.4.2 Astex Pharmaceuticals, Inc. Product Information
      • 4.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price and Gross Margin
      • 4.4.4 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Business Performance
      • 4.4.5 SWOT Analysis
    • 4.5 Blueprint Medicines Corporation
      • 4.5.1 Blueprint Medicines Corporation Profiles
      • 4.5.2 Blueprint Medicines Corporation Product Information
      • 4.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price and Gross Margin
      • 4.5.4 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Business Performance
      • 4.5.5 SWOT Analysis
    • 4.6 Boston Biomedical, Inc.
      • 4.6.1 Boston Biomedical, Inc. Profiles
      • 4.6.2 Boston Biomedical, Inc. Product Information
      • 4.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price and Gross Margin
      • 4.6.4 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Business Performance
      • 4.6.5 SWOT Analysis
    • 4.7 Calithera Biosciences, Inc.
      • 4.7.1 Calithera Biosciences, Inc. Profiles
      • 4.7.2 Calithera Biosciences, Inc. Product Information
      • 4.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price and Gross Margin
      • 4.7.4 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Business Performance
      • 4.7.5 SWOT Analysis
    • 4.8 Chipscreen Biosciences Ltd
      • 4.8.1 Chipscreen Biosciences Ltd Profiles
      • 4.8.2 Chipscreen Biosciences Ltd Product Information
      • 4.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price and Gross Margin
      • 4.8.4 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Business Performance
      • 4.8.5 SWOT Analysis
    • 4.9 Deciphera Pharmaceuticals, LLC
      • 4.9.1 Deciphera Pharmaceuticals, LLC Profiles
      • 4.9.2 Deciphera Pharmaceuticals, LLC Product Information
      • 4.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price and Gross Margin
      • 4.9.4 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Business Performance
      • 4.9.5 SWOT Analysis
    • 4.10 F. Hoffmann-La Roche Ltd.
      • 4.10.1 F. Hoffmann-La Roche Ltd. Profiles
      • 4.10.2 F. Hoffmann-La Roche Ltd. Product Information
      • 4.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price and Gross Margin
      • 4.10.4 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Business Performance
      • 4.10.5 SWOT Analysis
    • 4.11 Horizon Pharma Plc
    • 4.12 Immunicum AB
    • 4.13 Jiangsu Hengrui Medicine Co., Ltd.
    • 4.14 Kolltan Pharmaceuticals, Inc.
    • 4.15 Natco Pharma Limited
    • 4.16 Nerviano Medical Sciences S.r.l.
    • 4.17 Novartis AG
    • 4.18 Omeros Corporation

    5 Competitive Landscape

    • 5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production (K Units) and Market Share by Manufacturers (2014-2020)
    • 5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (M USD) and Market Share by Manufacturers (2014-2020)
    • 5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Unit) of Manufacturers (2014-2020)
    • 5.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Gross Margin of Manufacturers (2014-2020)
    • 5.5 Market Concentration

    6 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Assessment by Regions

    • 6.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production (K Units) and Market Share by Regions (2014-2020)
    • 6.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (M USD) and Market Share by Regions (2014-2020)
    • 6.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Unit) by Regions (2014-2020)
    • 6.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Gross Margin by Regions (2014-2020)

    7 Gastrointestinal Stromal Tumor (GIST) Drug Regional Analysis

    • 7.1 China Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue and Growth Rate (2014-2020)
    • 7.2 USA Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue and Growth Rate (2014-2020)
    • 7.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue and Growth Rate (2014-2020)
    • 7.4 Japan Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue and Growth Rate (2014-2020)
    • 7.5 Korea Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue and Growth Rate (2014-2020)
    • 7.6 India Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue and Growth Rate (2014-2020)
    • 7.7 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue and Growth Rate (2014-2020)
    • 7.8 South America Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue and Growth Rate (2014-2020)

    8 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Assessment

    • 8.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Market Share by Regions (2014-2020)
    • 8.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value and Market Share by Regions (2014-2020)
    • 8.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price (USD/Unit) by Regions (2014-2020)

    9 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Assessment by Regions

    • 9.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales and Sales Value (2014-2020)
    • 9.2 China Gastrointestinal Stromal Tumor (GIST) Drug Sales and Sales Value (2014-2020)
    • 9.3 USA Gastrointestinal Stromal Tumor (GIST) Drug Sales and Sales Value (2014-2020)
    • 9.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales and Sales Value (2014-2020)
    • 9.5 Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales and Sales Value (2014-2020)
    • 9.6 Korea Gastrointestinal Stromal Tumor (GIST) Drug Sales and Sales Value (2014-2020)
    • 9.7 India Gastrointestinal Stromal Tumor (GIST) Drug Sales and Sales Value (2014-2020)
    • 9.8 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Sales Value (2014-2020)
    • 9.9 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales and Sales Value (2014-2020)

    10 Technology and Cost

    • 10.1 Technology
    • 10.2 Cost

    11 Channel Analysis

    • 11.1 Market Channel
    • 11.2 Distributors

    12 Market Forecast 2021-2026

    • 12.1 Production and Revenue Forecast 2021-2026
      • 12.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production and Revenue by Regions 2021-2026
      • 12.1.2 China Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue and Growth Rate 2021-2026
      • 12.1.3 USA Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue and Growth Rate 2021-2026
      • 12.1.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue and Growth Rate 2021-2026
      • 12.1.5 Japan Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue and Growth Rate 2021-2026
      • 12.1.6 Korea Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue and Growth Rate 2021-2026
      • 12.1.7 India Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue and Growth Rate 2021-2026
      • 12.1.8 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue and Growth Rate 2021-2026
      • 12.1.9 South America Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue and Growth Rate 2021-2026
    • 12.2 Sales and Sales Value Forecast 2021-2026
      • 12.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Consumption Calue by Regions 2021-2026
      • 12.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales and Sales Value Forecast 2021-2026
      • 12.2.3 China Gastrointestinal Stromal Tumor (GIST) Drug Sales, Sales Value and Growth Rate 2021-2026
      • 12.2.4 USA Gastrointestinal Stromal Tumor (GIST) Drug Sales and Sales Value Forecast 2021-2026
      • 12.2.5 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales and Sales Value Forecast 2021-2026
      • 12.2.6 Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales and Sales Value Forecast 2021-2026
      • 12.2.7 Korea Gastrointestinal Stromal Tumor (GIST) Drug Sales and Sales Value Forecast 2021-2026
      • 12.2.8 India Gastrointestinal Stromal Tumor (GIST) Drug Sales and Sales Value Forecast 2021-2026
      • 12.2.9 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Sales Value Forecast 2021-2026
      • 12.2.10 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales and Sales Value Forecast 2021-2026
    • 12.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Production and Revenue Forecast by Type 2021-2026
      • 12.3.1 Overall Market Performance
      • 12.3.2 Amcasertib
      • 12.3.3 Anagrelide hydrochloride CR
      • 12.3.4 APG-1351
      • 12.3.5 Binimetinib
      • 12.3.6 Others
    • 12.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Application 2021-2026
      • 12.4.1 Overall Market Performance
      • 12.4.2 Clinic
      • 12.4.3 Hospital
      • 12.4.4 Others
    • 12.5 Global Gastrointestinal Stromal Tumor (GIST) Drug Price and Gross Margin Forecast
      • 13.5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Averages Price Development Trend Forecast 2021-2026
      • 13.5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Gross Margin Development Trend Forecast 2021-2026

    13 Conclusion

    Summary:
    Get latest Market Research Reports on Gastrointestinal Stromal Tumor (GIST) Drug. Industry analysis & Market Report on Gastrointestinal Stromal Tumor (GIST) Drug is a syndicated market report, published as Global Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis 2020 with Top Companies, Production, Consumption,Price and Growth Rate. It is complete Research Study and Industry Analysis of Gastrointestinal Stromal Tumor (GIST) Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$2,760.00
    		$5,500.00
    		2,265.96
    		4,515.50
    		2,685.48
    		5,351.50
    		430,532.40
    		857,945.00
    		239,126.40
    		476,520.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo